SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit

NEW YORK, March 26, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers and acquirers of Sana Biotechnology, Inc. (NASDAQ: SANA) securities between March 17, 2023 and November 17, 2024,…